Viewing data from:

GATIFLOXACIN

ANDA

GATIFLOXACIN | A206446 | RISING PHARMA HOLDINGS INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain7 active DMFs7 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

KYORIN PHARMACEUTICAL CO LTDGATIFLOXACIN DRUG SUBSTANCE

DMF 155972001

DR REDDYS LABORATORIES LTDGATIFLOXACIN ANHYDROUS

DMF 170122003

MATRIX PHARMACORP PRIVATE LTDGATIFLOXACIN

DMF 170132003

APOTEX PHARMACHEM INDIA PVT LTDGATIFLOXACIN HEMIHYDRATE

DMF 206852007

LUPIN LTDGATIFLOXACIN

DMF 235522010

APITORIA PHARMA PRIVATE LTDGATIFLOXACIN HEMIHYDRATE (NON-STERILE DRUG SUBSTANCE)

DMF 264522012

STHREE CHEMICALS PRIVATE LTDGATIFLOXACIN SESQUIHYDRATE

DMF 407522024

KYORIN PHARMACEUTICAL CO LTDInactiveGATIFLOXACIN

DMF 139021998

TEVA GROUPInactiveGATIFLOXACIN

DMF 169652003

CADILA HEALTHCARE LTDInactiveGATIFLOXACIN ANHYDROUS

DMF 170022003

CADILA HEALTHCARE LTDInactiveGATIFLOXACIN SESQUIHYDRATE

DMF 170922004

HETERO DRUGS LTDInactiveGATIFLOXACIN HEMIHYDRATE

DMF 171102004

UQUIFA MEXICO SA DE CVInactiveGATIFLOXACIN HEMIHYDRATE

DMF 178222004

SIGNA SA DE CVInactiveGATIFLOXACIN HEMIHYDRATE

DMF 309992016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.5%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Jun 8, 2018

No patent or exclusivity listings for this strength.